CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
7 stories
🇧🇷 G1 (PT)
National & Local

'Heart' in the stock market: woman who could not receive a transplant has lived with a half-million-dollar device for 8 years in RS

A Brazilian woman has successfully lived with an artificial heart for eight years, celebrating her life despite the device's challenges and high cost.

Mar 14 • 08:01 UTC
🇩🇪 FAZ
National & Local

New Catheter Technology: Unique Insights into the Heart

The Kerckhoff Clinic in Bad Nauheim is pilot testing the world's most advanced heart catheter system before its official market launch, featuring AI that improves imaging and reduces radiation exposure for patients.

Mar 13 • 14:22 UTC
🇩🇪 SZ
National & Local

Biontech: 'Heart and Brain'

Uğur Şahin and Özlem Türeci, the co-founders of Biotech company Biontech, will step down from their executive roles at the end of 2026 to start a new venture focused on mRNA and AI.

Mar 10 • 15:34 UTC
🇧🇷 G1 (PT)
National & Local

AI can identify the risk of severe heart diseases from mammograms; understand the relationship

Artificial intelligence can predict cardiovascular disease risk in women by analyzing mammograms, according to a study from the European Society of Cardiology.

Mar 9 • 07:01 UTC
🇶🇦 Al Jazeera
National & Local

Officially, OpenAI is at the heart of the US Department of Defense

OpenAI has signed an official agreement with the US Department of Defense to deploy advanced AI models within the military's classified cloud networks.

Mar 2 • 07:56 UTC
🇮🇹 La Repubblica
National & Local

An artificial heart or stopping treatments, the doctors' dilemma

Doctors face a critical decision regarding whether to pursue an artificial heart for a child waiting for a transplant or to halt treatments due to deteriorating conditions.

Feb 17 • 00:00 UTC
🇫🇷 Le Figaro
Life & Tech

The Carmat company liquidated, a new step for the artificial heart specialist

French company Carmat, which had been under judicial recovery since July, is being liquidated and will be succeeded by a new private entity taking over its activity of developing artificial hearts.

Jan 6 • 18:22 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.